We are monitoring the impact of COVID-19 on Europe Prostate Cancer Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1538
Share on
Share on

Europe Prostate Cancer Market Research Report - Segmented By Diagnostic Techniques, Surgery, Radiation Therapy, Chemotherapy, By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Size, Share, Growth, Trends & Forecast (2020 to 2025)

Pulished: February, 2020
ID: 1538
Pages: 145

Europe Prostate Cancer Market Size (2020 to 2025)

The size of the Prostate Cancer Market in Europe was valued at USD 16.69 billion in 2020 and estimated to be growing at a CAGR of 9.1%, to reach USD 25.8 billion by 2025. Market access restrictions to high-cost agents for prostate cancer are increasingly influential in European markets.

Prostate cancer is a commercially profitable indication with a high amount of diagnosis incidences. The drug treatment of prostate cancer has evolved quickly over the last few years with the metastatic castrate-resistant prostate cancer (mCRPC) situation becoming more and more crowded and competitive.

Rising incidence of prostate cancer is recognized as a major driver for the growth of the prostate cancer market during the forecast period. Some other drivers are increasing geriatric population base, growing demand for novel drugs and the existence of high unmet needs. Factors restraining market growth include high treatment costs and low patient compliance due to complicated treatment methods.

Europe Prostate Cancer Market segmented and sub-segmented into the following categories.

  • By Diagnostic Techniques: Digital Rectal Exam (DRE), Prostate-Specific Antigen Test (PSA).
  • By Surgery: Radial Prostatectomy, Orchidectomy, Trans Urethral Resection (TUR).
  • By Radiation Therapy: External Beam Radiation Therapy, Brachytherapy.
  • By Chemotherapy: Docetaxel, Etoposide, Vinblastine, Carboplatin, Vinorelbine.
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe.

Top Companies dominating the Europe Prostate Cancer Market Profiled in the Report are Sanofi S.A, GlaxoSmithKline, AstraZeneca, AbbVie, Varian Medical Systems, Elekta, Theragenics, Pfizer, Novartis, Roche, Bayer, Johnson & Johnson, Abbott Laboratories, and Genentech, etc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Diagnostic Techniques                           

                                5.1.1 Introduction           

                                5.1.2 Digital Rectal Exam (DRE)  

                                5.1.3 Prostate Specific Antigen Test (PSA)            

                                5.1.4 Y-o-Y Growth Analysis, By Product

                                5.1.5 Market Attractiveness Analysis, By Product               

                                5.1.6 Market Share Analysis, By Product                

                5.2 Surgery                        

                                5.2.1 Introduction           

                                5.2.2 Radical Prostatectomy       

                                5.2.3 Orchidectomy        

                                5.2.4 Trans Urethral Resection (TUR)      

                                5.2.5 Y-o-Y Growth Analysis, By Type      

                                5.2.6 Market Attractiveness Analysis, By Type     

                                5.2.7 Market Share Analysis, By Type      

                5.3 Radiation Therapy                   

                                5.3.1 Introduction           

                                5.3.2 External Beam Radiation Therapy  

                                                5.3.2.1 3D Conformal Radiation Therapy

                                                5.3.2.2 Intensity Modulated Radiation Therapy

                                                5.3.2.3 Stereotactic Body Radiation Therapy

                                                5.3.2.4 Proton Beam Radiation Therapy

                                5.3.3 Brachytherapy      

                                                5.3.3.1 Permanent Brachytherapy

                                                5.3.3.2 Temporary Brachytherapy

                                5.3.4 Y-o-Y Growth Analysis, By Application         

                                5.3.5 Market Attractiveness Analysis, By Application        

                                5.3.6 Market Share Analysis, By Application         

                5.4 Chemotherapy                         

                                5.4.1 Introduction           

                                5.4.2 Docetaxel

                                5.4.3 Etoposide

                                5.4.4 Vinblastine             

                                5.4.5 Carboplatin             

                                5.4.6 Vinorelbine            

                                5.4.7 Y-o-Y Growth Analysis, By Disease Indications          

                                5.4.8 Market Attractiveness Analysis, By Disease Indications        

                                5.4.9 Market Share Analysis, By Disease Indications         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Diagnostic Techniques

                                                6.1.3.3 By Surgery

                                                6.1.3.4 By Radiation Therapy

                                                6.1.3.5 By Chemotherapy

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Diagnostic Techniques

                                                6.1.4.3 By Surgery

                                                6.1.4.4 By Radiation Therapy

                                                6.1.4.5 By Chemotherapy

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Diagnostic Techniques

                                                6.1.5.3 By Surgery

                                                6.1.5.4 By Radiation Therapy

                                                6.1.5.5 By Chemotherapy

                6.2 U.K                

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Sanofi S.A                    

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GlaxoSmithKline                      

                8.3 AstraZeneca               

                8.4 AbbVie                         

                8.5 Varian Medical Systems                        

                8.6 Elekta                           

                8.7 Theragenics               

                8.8 Pfizer                            

                8.9 Novartis                       

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Europe Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025 (USD Million)
  2. Europe Digital Rectal Exam (DRE) Market, By Region, From 2020 to 2025 (USD Million)
  3. Europe Prostate Specific Antigen Test (PSA) Market, By Region, From 2020 to 2025 (USD Million)
  4. Europe Prostate Cancer Market, By Surgery, From 2020 to 2025 (USD Million)
  5. Europe Radical Prostatectomy Market, By Region, From 2020 to 2025 (USD Million)
  6. Europe Orchidectomy Market, By Region, From 2020 to 2025 (USD Million)
  7. Europe Trans Urethral Resection (TUR) Market, By Region, From 2020 to 2025 (USD Million)
  8. Europe Prostate Cancer Market, By Radiation Therapy , From 2020 to 2025 (USD Million)
  9. Europe External Beam Radiation Therapy Market, By Region, From 2020 to 2025 (USD Million)
  10. Europe Brachytherapy Market, By Region, From 2020 to 2025 (USD Million)
  11. Europe Prostate Cancer Market, By Chemotherapy , From 2020 to 2025 (USD Million)
  12. Europe Docetaxel Market, By Region, From 2020 to 2025 (USD Million)
  13. Europe Etoposide Market, By Region, From 2020 to 2025 (USD Million)
  14. Europe Vinblastine Market, By Region, From 2020 to 2025 (USD Million)
  15. Europe Carboplatin Market, By Region, From 2020 to 2025 (USD Million)
  16. Europe Vinorelbine Market, By Region, From 2020 to 2025 (USD Million)
  17. U.K. Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025 (USD Million)
  18. U.K. Prostate Cancer Market, By Surgery, From 2020 to 2025 (USD Million)
  19. U.K. Prostate Cancer Market, By Radiation Therapy , From 2020 to 2025 (USD Million)
  20. U.K. Prostate Cancer Market, By Chemotherapy , From 2020 to 2025 (USD Million)
  21. Germany Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025 (USD Million)
  22. Germany Prostate Cancer Market, By Surgery, From 2020 to 2025 (USD Million)
  23. Germany Prostate Cancer Market, By Radiation Therapy , From 2020 to 2025 (USD Million)
  24. Germany Prostate Cancer Market, By Chemotherapy , From 2020 to 2025 (USD Million)
  25. France Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025 (USD Million)
  26. France Prostate Cancer Market, By Surgery, From 2020 to 2025 (USD Million)
  27. France Prostate Cancer Market, By Radiation Therapy , From 2020 to 2025 (USD Million)
  28. France Prostate Cancer Market, By Chemotherapy , From 2020 to 2025 (USD Million)
  29. Italy Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025 (USD Million)
  30. Italy Prostate Cancer Market, By Surgery, From 2020 to 2025 (USD Million)
  31. Italy Prostate Cancer Market, By Radiation Therapy , From 2020 to 2025 (USD Million)
  32. Italy Prostate Cancer Market, By Chemotherapy , From 2020 to 2025 (USD Million)
  33. Spain Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025 (USD Million)
  34. Spain Prostate Cancer Market, By Surgery, From 2020 to 2025 (USD Million)
  35. Spain Prostate Cancer Market, By Radiation Therapy , From 2020 to 2025 (USD Million)
  36. Spain Prostate Cancer Market, By Chemotherapy , From 2020 to 2025 (USD Million)
  37. Europe Prostate Cancer Market, By External Beam Radiation Therapy , From 2020 to 2025 (USD Million)
  38. Europe 3D Conformal Radiation Therapy Market, By Region, From 2020 to 2025 (USD Million)
  39. Europe Intensity Modulated Radiation Therapy Market, By Region, From 2020 to 2025 (USD Million)
  40. Europe Stereotactic Body Radiation Therapy Market, By Region, From 2020 to 2025 (USD Million)
  41. Europe Proton Beam Radiation Therapy Market, By Region, From 2020 to 2025 (USD Million)
  42. U.K. Prostate Cancer Market, By External Beam Radiation Therapy , From 2020 to 2025 (USD Million)
  43. Germany Prostate Cancer Market, By External Beam Radiation Therapy , From 2020 to 2025 (USD Million)
  44. France Prostate Cancer Market, By External Beam Radiation Therapy , From 2020 to 2025 (USD Million)
  45. Italy Prostate Cancer Market, By External Beam Radiation Therapy , From 2020 to 2025 (USD Million)
  46. Spain Prostate Cancer Market, By External Beam Radiation Therapy , From 2020 to 2025 (USD Million)
  47. Europe Prostate Cancer Market, By Brachytherapy, From 2020 to 2025 (USD Million)
  48. Europe Permanent Brachytherapy Market, By Region, From 2020 to 2025 (USD Million)
  49. Europe Temporary Brachytherapy Market, By Region, From 2020 to 2025 (USD Million)
  50. U.K. Prostate Cancer Market, By Brachytherapy, From 2020 to 2025 (USD Million)
  51. Germany Prostate Cancer Market, By Brachytherapy, From 2020 to 2025 (USD Million)
  52. France Prostate Cancer Market, By Brachytherapy, From 2020 to 2025 (USD Million)
  53. Italy Prostate Cancer Market, By Brachytherapy, From 2020 to 2025 (USD Million)
  54. Spain Prostate Cancer Market, By Brachytherapy, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample